Effects of multiple-target anti-microRNA antisense oligodeoxyribonucleotides on proliferation and migration of gastric cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3203-3207

  Xu, Ling ^a   Dai, Wei Qi ^a   Xu, Xuan Fu ^a   Wang, Fan ^a   He, Lei ^a   Guo, Chuan Yong ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Antisense; Cell proliferation; Micrornas; Migration; Oligonucleotides; Stomach neoplasms

Indexed keywords

EID: 84873599074     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3203     Document Type: Article

References (19)

1. Bartels CL and Tsongalis GJ. (2009). MicroRNAs: novel biomarkers for human cancer. Clin Chem, 55, 623-31.
2. Chen CF, Ridzon DA and Broomer AJ, et al. (2005). Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res, 33, e179.
3. Chen Y, Stallings RL. (2007). Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res, 67, 976-83.
4. Denli AM, Tops BJ, Plasterk PH, et al. (2004). Processing of primary microRNAs by the microprocessor complex. Nature, 432, 231-5.
5. Esquela-Kerscher A and Slack FJ. (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69.
6. Ferdin J, Kunej T and Calin GA. (2010). Non-coding RNAs: Identification of Cancer-Associated microRNAs by Gene Profiling. Technol Cancer Res Treat, 9, 123-38.
7. Gregory RI, Yan K, Amuthan G, et al. (2004). The microprocessor complex mediates the genesis of microRNAs. Nature, 432, 235-40.
8. Krützfeldt J, Rajewsky N, Braich R, et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature, 438, 685-9.
9. Lee EJ, Gusev Y, Jiang J, et al. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer, 120, 1046-54.
10. Liu W, Mao SY and Zhu WY. (2007). Impact of tiny miRNAs on cancers. World J Gastroenterol, 13, 497-502.
11. Ørom UA, Kauppinen S, Lund AH. (2006). LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene, 372, 137-41.
12. Schetter AJ, Leung SY, Sohn JJ, et al. (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA, 299, 425-36.
13. Li C, Feng Y, Coukos G, et al. (2009). Therapeutic microRNA strategies in human cancer. AAPS J, 11, 747-57.
14. Lu Y, Xiao J, Lin H, et al. (2009). A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res, 37, e24.
15. Wagner RW. (1994). Gene inhibition using antisense oligodeoxynucleotides. Nature, 372, 333-5.
16. Wang V and Wu W. (2009). MicroRNA-based therapeutics for cancer. BioDrugs, 23, 15-23.
17. Weiler J, Hunziker J, Hall J. (2006). Anti-miRNA-oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease. Gene Ther, 13, 496-502.
18. Xiao B, Guo J, Miao Y, et al. (2009). Detection of miR-106a in gastric carcinoma and its clinical significance. Clin Chim Acta, 400, 97-102.
19. Yanaihara N, Caplen N, Bowman E, et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-98.